Literature DB >> 31991334

Celastrol: Progresses in structure-modifications, structure-activity relationships, pharmacology and toxicology.

Wei Hou1, Bo Liu2, Hongtao Xu3.   

Abstract

Celastrol, a principal bioactive ingredient of Tripterygium wilfordii Hook F, has gained extensive exploration due to its unique structure features and multiple promising biological activities. This review will focus on the structural modifications, structure-activity relationships, pharmacology, and toxicology of celastrol in the past ten years. We hope this review would be helpful to get a better grasp of the progresses in the field and provide constructive suggestions for the further study of celastrol.
Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cancer; Celastrol; Diabetes; Inflammatory; Medicinal chemistry; Obese; Pharmacology and toxicology; Toxicity; Tripterygium wilfordii hook F.

Mesh:

Substances:

Year:  2020        PMID: 31991334     DOI: 10.1016/j.ejmech.2020.112081

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  23 in total

Review 1.  Role of autophagy in drug resistance and regulation of osteosarcoma (Review).

Authors:  Yanchuan Pu; Jin Wang; Shizhong Wang
Journal:  Mol Clin Oncol       Date:  2022-02-01

2.  Molecular mechanism of ovarian toxicity of Hook.F. a study based on network pharmacology and molecular docking.

Authors:  Zhiqiang Wang; Caixia Gong; Zhenbin Li
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2022-02-25

3.  Native Endophytes of Tripterygium wilfordii-Mediated Biotransformation Reduces Toxicity of Celastrol.

Authors:  Ping-Yang Ma; Wei-Ling Geng; Hong-Yan Ji; Bang-Wen Yue; Cheng Liu; Sa Wang; Zhi-Bo Jiang; Jing Chen; Xiu-Li Wu
Journal:  Front Microbiol       Date:  2022-05-25       Impact factor: 6.064

Review 4.  Celastrol: A Review of Useful Strategies Overcoming its Limitation in Anticancer Application.

Authors:  Jinfeng Shi; Jiaxin Li; Ziyi Xu; Liang Chen; Ruifeng Luo; Chen Zhang; Fei Gao; Jinming Zhang; Chaomei Fu
Journal:  Front Pharmacol       Date:  2020-11-18       Impact factor: 5.810

5.  Antimicrobial Activity and Mode of Action of Celastrol, a Nortriterpen Quinone Isolated from Natural Sources.

Authors:  Nayely Padilla-Montaño; Leandro de León Guerra; Laila Moujir
Journal:  Foods       Date:  2021-03-11

6.  Celastrol Modulates Multiple Signaling Pathways to Inhibit Proliferation of Pancreatic Cancer via DDIT3 and ATF3 Up-Regulation and RRM2 and MCM4 Down-Regulation.

Authors:  Mahmoud Youns; Momen Askoura; Hisham A Abbas; Gouda H Attia; Ahdab N Khayyat; Reham M Goda; Ahmad J Almalki; El-Sayed Khafagy; Wael A H Hegazy
Journal:  Onco Targets Ther       Date:  2021-06-23       Impact factor: 4.147

Review 7.  Nanotechnology-Based Celastrol Formulations and Their Therapeutic Applications.

Authors:  Pushkaraj Rajendra Wagh; Preshita Desai; Sunil Prabhu; Jeffrey Wang
Journal:  Front Pharmacol       Date:  2021-06-11       Impact factor: 5.810

Review 8.  Naturally Derived Heme-Oxygenase 1 Inducers and Their Therapeutic Application to Immune-Mediated Diseases.

Authors:  Samanta C Funes; Mariana Rios; Ayleen Fernández-Fierro; Camila Covián; Susan M Bueno; Claudia A Riedel; Juan Pablo Mackern-Oberti; Alexis M Kalergis
Journal:  Front Immunol       Date:  2020-07-23       Impact factor: 7.561

Review 9.  Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant.

Authors:  Elaine C D Gonçalves; Gabriela M Baldasso; Maíra A Bicca; Rodrigo S Paes; Raffaele Capasso; Rafael C Dutra
Journal:  Molecules       Date:  2020-03-29       Impact factor: 4.411

10.  Celastrol induces ROS-mediated apoptosis via directly targeting peroxiredoxin-2 in gastric cancer cells.

Authors:  Xi Chen; Ying Zhao; Wu Luo; Sian Chen; Feng Lin; Xi Zhang; Shijie Fan; Xian Shen; Yi Wang; Guang Liang
Journal:  Theranostics       Date:  2020-08-15       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.